Directory
>
Shifeng Pan
Shifeng Pan
Chief Scientific Officer | Genesis Therapeutics
San Diego, California, United States
Shifeng Pan
Summary
Shifeng Pan is a seasoned Chief Scientific Officer at Genesis Therapeutics, bringing a wealth of experience in the commercial physical research sector. With a strong academic foundation, including a PhD in Organic and Medicinal Chemistry from New York University, Shifeng has dedicated over two decades to advancing scientific discovery. His leadership roles at various organizations, including Odyssey Therapeutics and GNF, highlight his commitment to innovation and excellence in research. Known for his strategic vision, he effectively bridges the gap between scientific inquiry and practical application. Shifeng's career is marked by a consistent trajectory of growth, culminating in his current position where he drives groundbreaking initiatives. His passion for chemistry is matched by a keen interest in emerging technologies that impact the pharmaceutical landscape. Shifeng is also deeply committed to mentoring the next generation of scientists, fostering a culture of collaboration and creativity. Residing in San Diego, California, he enjoys the vibrant scientific community and the opportunities it presents for interdisciplinary collaboration.
Shifeng Pan
Work Experience
Chief Scientific Officer at
Genesis Therapeutics
April 2024 - Present
EVP and Head of Discovery at
Odyssey Therapeutics, Inc.
July 2021 - April 2024
Executive Director of Discovery Chemistry at
GNF
March 2013 - July 2021
Associate Director of Medicinal Chemistry at
GNF
March 2008 - February 2013
Group Leader at
GNF
March 2004 - February 2008
Senior Principal Investigator at
GNF
March 2002 - February 2004
Principal Investigator at
GNF
January 2001 - February 2002
Postdoctoral Associate at
GNF
December 1999 - December 2000
Shifeng Pan
Education
Fudan University, Bachelor's Degree
January 1989 - January 1993
New York University, Phd
Frequently Asked Questions about Shifeng Pan
What is Shifeng Pan email address?
Shifeng Pan's primary email address is ****@gnf.org. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Shifeng Pan work for?
Shifeng Pan is a Chief Scientific Officer at Genesis Therapeutics, a company specializing in Commercial physical research.
Where Shifeng Pan graduated from?
Shifeng Pan holds a degree in Chemistry from Fudan University.
How can I directly contact Shifeng Pan?
To contact Shifeng Pan directly, you can use the email address ****@gnf.org. Complete contact information is available upon registration with Muraena.
Who is Shifeng Pan?
Shifeng Pan is a seasoned Chief Scientific Officer at Genesis Therapeutics, bringing a wealth of experience in the commercial physical research sector. With a strong academic foundation, including a PhD in Organic and Medicinal Chemistry from New York University, Shifeng has dedicated over two decades to advancing scientific discovery. His leadership roles at various organizations, including Odyssey Therapeutics and GNF, highlight his commitment to innovation and excellence in research. Known for his strategic vision, he effectively bridges the gap between scientific inquiry and practical application. Shifeng's career is marked by a consistent trajectory of growth, culminating in his current position where he drives groundbreaking initiatives. His passion for chemistry is matched by a keen interest in emerging technologies that impact the pharmaceutical landscape. Shifeng is also deeply committed to mentoring the next generation of scientists, fostering a culture of collaboration and creativity. Residing in San Diego, California, he enjoys the vibrant scientific community and the opportunities it presents for interdisciplinary collaboration.
Shifeng`s contact details
****@gnf.org
****@odysseytx.com
*******@genesistherapeutics.ai
Colleagues
Senior VP of Biology
Founder and CEO
Owner and founder
VP Program and Alliance Management
Founder and CEO
Vice President of Chemistry
Vice President/Business Strategy at PhenoTarget
Executive Director Medicinal Chemistry